COVID-19 Miniseries Episode 57: Transcending the Valley of Death - COVID-19 mRNA Vaccine Update
Mayo Clinic Talks21 Joulu 2020

COVID-19 Miniseries Episode 57: Transcending the Valley of Death - COVID-19 mRNA Vaccine Update

This episode was recorded on December 18, 2020.

To claim credit visit: https://ce.mayo.edu/covid19podcast

Guest: Gregory A. Poland, M.D. (@drgregpoland)

Host: Amit K. Ghosh, M.D., M.B.A. (@AmitGhosh006)

It is projected that by March of 2021 1:700 Americans will have died of COVID-19. The historic pace of COVID-19 vaccine development was made possible by the countless sacrifices of many individuals across healthcare, research, health and human services, the Department of Defense, and other key sectors. This interprofessional collaboration required many to set life aside and work tirelessly to bring an effective vaccine to market, quickly. While mRNA vaccines have been in development since the 1990s, the COVID-19 vaccine efficacy rate of 95-100% across studied ages, race and ethnicities, and comorbidities is unprecedented. The questions left to answer are, how long will the efficacy last? In larger population studies, what is the safety/allergy/hypersensitivity profile? What impact does the vaccine have on asymptomatic carrier spread? Who shouldn’t get the vaccine? Dr. Greg Poland breaks down everything you need to know about the mRNA COVID-19 vaccines.

Additional Resources:

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Jaksot(500)

Heart Health Series | Cardiotoxicity of Cancer Therapies

Heart Health Series | Cardiotoxicity of Cancer Therapies

Host: Darryl S. Chutka, M.D.  Guest: Balaji Tamarappoo, M.D., Ph.D.  With advances in oncology, patients are living longer than ever following a diagnosis of cancer. Newer treatments have dramatically...

24 Helmi 26min

Heart Health Series | Pericardial Disease

Heart Health Series | Pericardial Disease

Host: Darryl S. Chutka, M.D.  Guest: Hema Narayanasamy, M.B.B.S.  Pericardial disease represents a spectrum of both inflammatory and non-inflammatory disorders which involve the pericardium, with acut...

17 Helmi 28min

The Power of Intervals: High Intensity Interval Training and Reducing Cardiovascular Risk

The Power of Intervals: High Intensity Interval Training and Reducing Cardiovascular Risk

Host: Darryl S. Chutka, M.D.  Guest: Stephen Kopecky, M.D.  We have a variety of pharmacologic options and lifestyle changes we recommend to our patients to reduce their cardiovascular risks. One freq...

10 Helmi 20min

Heart Health Series | Bicuspid Aortic Valve Disease

Heart Health Series | Bicuspid Aortic Valve Disease

Host: Darryl S. Chutka, M.D.  Guest: George Wang, M.D.  Bicuspid aortic valve is a relatively common congenital heart disease. It can be associated with other genetic disorders such as Turner’s Syndro...

5 Helmi 29min

Heart Health Series | Cardiac Amyloidosis

Heart Health Series | Cardiac Amyloidosis

Host: Darryl S. Chutka, M.D.  Guest: Julie Rosenthal, M.D.  Cardiac amyloidosis is not a common condition, but it is important for primary care clinicians to recognize it in our patients. It’s commonl...

3 Helmi 29min

Concussions: What Every Primary Care Provider Should Know

Concussions: What Every Primary Care Provider Should Know

Host: Darryl S. Chutka, M.D. Guest: Matthew B. Anastasi, M.D. Patients with concussions are commonly seen in primary care practices and concussions don’t spare any particular age group. Children, youn...

27 Tammi 27min

Rx for Weight Loss: A Closer Look Series "The Wins of Losing: GLP-1 Agonists and Reducing Heart Disease Risk"

Rx for Weight Loss: A Closer Look Series "The Wins of Losing: GLP-1 Agonists and Reducing Heart Disease Risk"

Host: Darryl S. Chutka, M.D.  Guest: Stephen Kopecky, M.D.  One of the biggest surprises we’ve seen in medicine in the past several years has been the numerous health benefits realized from the GLP-1 ...

20 Tammi 20min

Rx for Weight Loss: A Closer Look Series "Controversies & Future of GLP-1 Medications"

Rx for Weight Loss: A Closer Look Series "Controversies & Future of GLP-1 Medications"

Host: Darryl S. Chutka, M.D.  Guests: Tamim I. Rajjo, M.D., M.P.H.; Meera Shah, M.B., Ch.B.  The class of medications known as the GLP-1 agonists is very popular with our patients. Although initially ...

15 Tammi 24min

Suosittua kategoriassa Koulutus

rss-murhan-anatomia
psykopodiaa-podcast
voi-hyvin-meditaatiot-2
adhd-podi
rss-narsisti
rss-rahamania
rss-vapaudu-voimaasi
psykologia
aamukahvilla
rss-liian-kuuma-peruna
rahapuhetta
rss-valo-minussa-2
kesken
jari-sarasvuo-podcast
mielipaivakirja
rss-tietoinen-yhteys-podcast-2
uskonnon-pitka-oppimaara
rss-eron-alkemiaa
rss-koira-haudattuna
rss-arkea-ja-aurinkoa-podcast-espanjasta